PAG
RVMD icon

Private Advisor Group’s Revolution Medicines RVMD Stock Holding History

Private Advisor Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$969K Sell
9,967
-3,462
-26% -$350K ﹤0.01% 1438
2025
Q4 		$1.07M Buy
13,429
+2,186
+19% +$143K 0.01% 1370
2025
Q3 		$525K Buy
+11,243
New +$440K ﹤0.01% 1754

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Private Advisor Group's RVMD Position: Q1 2026 in Review

Private Advisor Group reduced its Revolution Medicines (RVMD) stake by 26% in Q1 2026, selling an estimated $350K and leaving 9,967 shares worth $969K. The position accounts for ﹤0.01% of the portfolio, ranked #1438.

Private Advisor Group first reported a position in RVMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.07M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Private Advisor Group held 9,967 shares of Revolution Medicines worth $969K as of Q1 2026.
  • Private Advisor Group sold 3,462 Revolution Medicines shares in Q1 2026, an estimated $350K.
  • Revolution Medicines made up ﹤0.01% of Private Advisor Group's portfolio in Q1 2026, its #1438 holding.
  • Private Advisor Group first reported a position in Revolution Medicines in Q3 2025 and has held it in 3 quarters since.
  • Private Advisor Group's Revolution Medicines position peaked at $1.07M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.